Authors: Orlando, M Chacon, M Salum, G Chacon, DR

Citation: M. Orlando et al., Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer, ANN ONCOL, 11(2), 2000, pp. 177-181